Moberg Pharma launches new patent pending formulation of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Moberg Pharma launches new patent pending formulation of Kerasal Nail in the U.S.

Moberg Pharma AB (OMX: MOB) announces that the company this week starts shipping a new patent pending formulation of its market leading product Kerasal Nail™ to U.S. customers. The new product is shipped as a flow-through and will be available at all existing retailers, including major drugstores CVS, Walgreens and Rite-Aid, mass retailers such as Walmart and Target and leading grocery chains such as Publix and Safeway. Current distribution of Kerasal Nail is estimated to more than 30 000 outlets in the U.S. Kerasal Nail™ is the market leading product in the OTC fungal nail category with 20% market share in the U.S. as of end 2013. The new formula provides benefits to consumers by improving user-friendliness, facilitating nail penetration and improving stability. Moberg Pharma has applied for patent protection for the new product. The projected expiry date for this new IP is in 2034. “I am very pleased to announce the launch of the improved formula. The new and improved Kerasal Nail™ demonstrates the value of our development approach, which continues to deliver innovative products with unique benefits to consumers. The new patent application can provide long term IP protection for our lead product”, said Peter Wolpert, CEO of Moberg Pharma AB. About this information Moberg Pharma discloses this information pursuant to the Swedish Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 08.30 am (CET) on March 24, 2014. For further information, please contact: Peter Wolpert, CEO, Moberg Pharma AB, telephone: +46 707 35 71 35, e-mail: peter.wolpert@mobergpharma.se Peter Östling, IR, Moberg Pharma AB, telephone: +46 76 301 09 78, e-mail: peter.ostling@mobergpharma.se About Moberg Pharma AB Moberg Pharma AB (publ) is a rapidly growing Swedish pharmaceutical company with its own sales organization in the US and sales through distributors in more than 40 countries. The company’s OTC portfolio includes the brands Kerasal®, Jointflex®, Kerasal Nail™Domeboro®, Vanquish®, Fergon®and Kaprolac®. Kerasal Nail™(Nalox™ in many markets) is the leading product for the treatment of nail disorders in the U.S and Nordic market. The portfolio is developed further through acquisitions and in-licensing of products as well as product development with focus on innovative drug delivery based on proven compounds. Moberg Pharma has offices in Stockholm and New Jersey and the company’s share (OMX: MOB) is listed on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm. For further information, please visit: www.mobergpharma.se.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EnGenius Unveils AI Infrastructure at SC26 Showcase

Updated Category News Views 23

AI Infrastructure Spotlight at SuperComputing 2026 Forget the usual buzzwords and smoke blows—we’re talking EnGenius Technologies pulling a full-court press at SC26, where they’ll flaunt their AI and edge computing chops from November 15–20. This ain't just about shiny tech displays; it’s a real-deal showcase at Chicago’s McCormick Place, and they’re running...

Continue Reading
Edelson Lechtzin Investigates Baanx Data Breach

Updated Category News Views 143

Inside the Baanx Data Breach: A Wake-Up Call The digital currency frontier is fraught with pitfalls, and the latest Baanx data breach saga is a sobering reminder. This isn't just a minor fumble—this one's a big, hairy mess involving sensitive data of Crypto Life users, causing ripples through an already jittery market. What Went Wrong with Baanx We're staring at...

Continue Reading
Cognex Delivers Record Q3 Results, Eyes Future Growth

Updated Category News Views 62

Shaking Up the Leaderboard with Record Revenues You want a testament to a well-oiled machine? Look no further than Cognex Corporation, flaunting a record quarterly revenue hitting $313 million. That's a hearty 13% uptick from last year. Peel back the layers, and excluding a one-time boon from a partnership last year, you're staring at a 19% year-over-year surge. Talk...

Continue Reading
NPA Champions Safe Transit Act for Safer Commutes

Updated Category News Views 18

Public Safety on the Line: The Safe Transit Act When city dwellers head to work or school, the last thing they want is a dicey subway ride. Yet, escalating incidents on transit lines are painting a grim picture. From folks getting pushed onto the tracks to outright assault, it's getting hairy out there. The NPA Puts Its Weight Behind Safety The National Police Association...

Continue Reading
Starting Pet End-of-Life Talks: Why Timing Matters

Updated Category News Views 109

Early Conversations Can Change Everything The minute you bring it up, let's be honest, nobody likes to talk about end-of-life decisions, not even for their pets. Yet, when you think about it, biding your time until things get critical isn't doing anyone any favors, especially not the furry ones. Drs. Brandon and Paola Beebout, two piercing minds from Kearney, Nebraska,...

Continue Reading
NSING's Bluetooth Milestone: A Signal for Investors

Updated Category News Views 91

The Bluetooth Bonanza: NSING Technologies' Big Win Amidst the bustling lanes of the semiconductor sector, NSING Technologies just threw down a whopper of an announcement—over 250 million Bluetooth chips shipped, all well-knitted with Ceva's technology. This isn’t just another milestone; it's a clarion call for anyone keeping an eye on the evolving landscape of...

Continue Reading
JT Mega Embraces New Leadership as Erin Denham Steps Up

Updated Category News Views 14

A New Captain at the Helm Erin Denham's promotion to president of JT Mega is setting the stage for some fresh momentum in the food and beverage advertising world. This Minnesotan agency, nestled right there on Minnetonka Boulevard, has been an independent force for five decades. It's a sector dominated by players who often get absorbed by the behemoth holding companies,...

Continue Reading
Manulife's Q3 2026: Strong Gains Amid Income Dip

Updated Category News Views 85

Manulife's Resilience in a Volatile Market Trading has a way of keeping folks on their toes. Just when you think you've ridden the bull long enough, it tries bucking you off. That's how it goes for Manulife Financial Corporation (TSX/NYSE/PSE: MFC), as they reported their Q3 2026 results—marking a seesaw of gains and losses. Core Earnings Shine While Net Income Declines...

Continue Reading
Talogy Unveils AI-Driven Leadership Assessment Tool

Updated Category News Views 33

Transforming Leadership in a Tech-Driven World In this whirlwind of a workplace, Talogy's decision to sprinkle a bit of AI magic into the leadership stew isn't just a nifty trick—it's the secret ingredient we never knew we needed. Amid the endless chatter about tech evolution, Talogy has tossed a new wrench into the leadership development gears: AI-powered simulations....

Continue Reading
Sabre's Q3 Earnings: What Investors Need to Know

Updated Category News Views 34

Unpacking Sabre's Latest Financial Reveal Sabre Corporation, that familiar name in travel tech, let the third quarter numbers out of the bag. Published fresh off the wire on November 5th, this round of figures covers the books up until September 30, 2026. If you're wired into NASDAQ:SABR, this is your bread and butter for the quarter. The figures, straight from Sabre's...

Continue Reading

Top 5 Most Recently Viewed Articles

Manulife Investment Management Completes Major Climate Fund Close

Updated Category News Views 321

Manulife Investment Management's Milestone in Forest Climate Fund Manulife Investment Management, a global leader in timberland investment management overseeing over five million acres, has recently achieved a significant milestone with the completion of the third and final close of the Manulife Forest Climate Fund LP. This fund has successfully garnered over $480.1...

Continue Reading
Sun Country Airlines Receives Buy Rating from TD Cowen Firm

Updated Category News Views 45

Sun Country Airlines Remains on TD Cowen's Positive Radar TD Cowen has reaffirmed its Buy rating on Sun Country Airlines Holdings (NASDAQ: SNCY), setting a steady price target of $20.00. This position indicates confidence in the airline's future despite underlying challenges anticipated in the upcoming quarters. Looking Ahead: Anticipated Results and Strategic Planning...

Continue Reading
Baxter International's Board Faces Probe for Fiduciary Issues

Updated Category News Views 193

Baxter International Inc.'s Board Under Scrutiny Baxter International Inc. (NYSE: BAX) is facing scrutiny as an investigation into its Board of Directors commences. This investigation, led by legal experts at Berger Montague, aims to examine possible breaches of fiduciary duties connected to the marketing and distribution of the Novum Large Volume Pump (Novum LVP)....

Continue Reading
Collaboration Between Heltec Automation and Morse Micro for IoT

Updated Category News Views 161

Innovative Partnership for IoT Connectivity Heltec Automation has teamed up with Morse Micro, a prominent name in Wi-Fi HaLow technology, to push the boundaries of Internet of Things (IoT) connectivity. This collaboration aims to create advanced solutions that cater to high-speed, low-power needs across various industries. Transforming IoT Solutions The newly formed...

Continue Reading
Bill Gates Highlights Boring Yet Crucial Health Topics

Updated Category News Views 231

Bill Gates Emphasizes Global Health Issues Microsoft co-founder and philanthropist Bill Gates has highlighted the importance of global health issues, expressing his surprise at the low public engagement regarding these critical topics. Significant Concerns Gates identifies challenges such as child mortality and malnutrition as crucial as high-profile discussions around...

Continue Reading